Severe Cytomegalovirus Gastritis During Natalizumab-Mediated Immunosuppression

We report a 35-year-old female receiving natalizumab as monotherapy for multiple sclerosis who subsequently developed severe cytomegalovirus gastritis. As cytomegalovirus gastritis has not been previously described during natalizumab treatment, we discuss the biological plausibility of this potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Persaud, Stephen P., Hassan, Adil, Hassan, Anjum, Hassan, Tariq
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Gastroenterology 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356152/
https://www.ncbi.nlm.nih.gov/pubmed/28331881
http://dx.doi.org/10.14309/crj.2017.43

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356152/
https://www.ncbi.nlm.nih.gov/pubmed/28331881
http://dx.doi.org/10.14309/crj.2017.43

Ejemplares similares